Scientists test Psychedelic-Like compound in first human safety trial
NCT ID NCT07399899
Summary
This is a very early study to understand the safety and basic effects of an experimental compound called NBX-100 in healthy people. Eight participants will receive increasing weekly doses of the drug while researchers closely monitor their physical health, drug levels in the blood, and psychological state. The main goal is to gather initial safety data and see how the body processes the compound before testing it in people with medical conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CMAX
Adelaide, South Australia, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.